Skip to main navigation Skip to search Skip to main content

The phage therapy paradigm: Prêt-à-porter or sur-mesure?

  • Jean Paul Pirnay
  • , Daniel De Vos
  • , Gilbert Verbeken
  • , Maia Merabishvili
  • , Nina Chanishvili
  • , Mario Vaneechoutte
  • , Martin Zizi
  • , Geert Laire
  • , Rob Lavigne
  • , Isabelle Huys
  • , Guy Van Den Mooter
  • , Angus Buckling
  • , Laurent Debarbieux
  • , Flavie Pouillot
  • , Joana Azeredo
  • , Elisabeth Kutter
  • , Alain Dublanchet
  • , Andrzej Górski
  • , Revaz Adamia
  • Military Hospital Queen Astrid
  • George Eliava Institute of Bacteriophage, Microbiology and Virology
  • University of Ghent
  • Vrije Universiteit Brussel
  • Adjoint Chief of Staff Health and Well-Being
  • KU Leuven
  • University of Oxford
  • Institut Pasteur, Paris
  • Pherecydes Pharma
  • Universidade do Minho
  • Evergreen State College
  • Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges
  • Medical University of Warsaw

Research output: Contribution to journalComment/debate

258 Citations (Scopus)
Original languageEnglish
Pages (from-to)934-937
Number of pages4
JournalPharmaceutical Research
Volume28
Issue number4
DOIs
Publication statusPublished - Apr 2011

Keywords

  • antibiotic resistance
  • bacterial infection
  • bacteriophages
  • drugs
  • phage therapy

Cite this